ITEMS IN AFP WITH KEYWORD:
Upper Respiratory Infections
Point-of-care C-reactive protein (CRP) testing used as an adjunct to a physician's clinical examination can modestly reduce antibiotic use. Measurement of CRP to guide antibiotic prescription does not appear to affect the duration of illness or recovery, although one study suggests that it increases the risk of hospitalization.
Oct 1, 2015 Issue
Probiotics for the Prevention of Upper Respiratory Tract Infections [Medicine by the Numbers]
Studies show that probiotics prevented 1 in 8 upper respiratory tract infections and caused no harms. Find out more.
What are the effects of interventions to reduce symptoms of acute infective sore throat?
This guideline on the diagnosis, management, and prevention of bronchiolitis in children one to 23 months of age from the American Academy of Pediatrics (AAP) updates a previous guideline published in 2006.
Dec 15, 2014 Issue
AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV Infection [Practice Guidelines]
The American Academy of Pediatrics (AAP) Committee on Infectious Diseases has updated its guidance on the use of palivizumab (Synagis) prophylaxis in infants and children at increased risk of respiratory syncytial virus (RSV) infection. Because the palivizumab package labeling does not include a def...
Advice regarding the use of steam inhalation, ibuprofen alone or with acetaminophen, acetaminophen alone, and regular vs. as-needed use of analgesics did not show any improved effectiveness in treating symptoms of acute respiratory tract infections. Ibuprofen may be beneficial in patients with chest...
A delayed prescription approach in children and adults with acute respiratory tract infections, combined with explicit instructions for symptom control, is effective in decreasing antibiotic use, while not adversely affecting patient satisfaction or symptom duration or severity.
Treating acute bronchitis with amoxicillin/clavulanate or the nonsteroidal anti-inflammatory drug ibuprofen is no more effective than placebo in decreasing symptoms in general or duration of frequent cough. Treatment does, however, produce adverse effects in one in eight patients.
Vitamin D supplementation, at a dosage of 100,000 IU per month for 18 months, did not reduce the incidence or severity of URIs in healthy adults. This is the third randomized controlled trial that showed no relationship between vitamin D levels and acute URIs.
Upper respiratory tract infections account for millions of visits to family physicians each year in the United States. Although warranted in some cases, antibiotics are greatly overused. This article outlines the guidelines and indications for appropriate antibiotic use for common upper respiratory ...